Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chitosan Scaffold and MTA Pulpotomy in Irreversible Pulpitis
NCT04308863Phase 2Completed
- Start
- Nov 2018
- Primary completion
- Oct 2020
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 2 trial of chitosan in irreversible pulpitis. Started Nov 2018; status: completed.
02
Drugs
chitosan
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT04308863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04308863.